INS and obesity disorder: Loss of Fabp5 gene expression leads to increased systemic insulin sensitivity in animal models of obesity and IR, and adipocytes isolated from Fabp5 -/- mice also exhibit increased insulin-stimulated glucose transport capacity [32].